• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扶正祛邪方联合化疗治疗进展期胃癌:158例患者随访研究及动物实验研究

[Treatment of operated late gastric carcinoma with prescription of strengthening the patient's resistance and dispelling the invading evil in combination with chemotherapy: follow-up study of 158 patients and experimental study in animals].

作者信息

Wang G T

机构信息

Ruijin Hospital, Shanghai Second Medical University.

出版信息

Zhong Xi Yi Jie He Za Zhi. 1990 Dec;10(12):712-6, 707.

PMID:2292115
Abstract

158 cases of late gastric carcinoma (11 males and 47 females, age 30-70 years) were treated postoperatively with TCM prescriptions of strengthening the patient's resistance and dispelling the invading evil in combination with chemotherapy. The main ingredients were Radix Codonopsis Pilosulae, Radix Astragali seu Hedysari, Rhizoma Atractylodes, Herba Solani Hyrati, Herba Oldenlandiae and Herba Salviae. The prescription was individualized by adding or subtracting some herbs according to TCM syndrome diagnosis at the time of patient's visit. The decoction was given daily for a long time, three to four years or even longer. It was given alone or together with regimes of chemotherapy at random. The average survival rates at 3 and 5 years were 41.07% and 30.36% respectively. Seven patients have lived for more than 11 years. 10 years survival rate was 12.5%. The combination of Chinese medicine with chemotherapy was better than chemotherapy regime alone (single 5-Fu or CCNU+5-Fu, MMF). Immunological studies of the survivors revealed an enhancement of both humoral and cellular immunity especially the function of peripheral NK cells. The decoction had been given to mice bearing Ehrlich ascites tumor. The amount of ascitic fluid was reduced and its cancer cell count decreased besides a significant increase in over-all survival rate of the animals. It suggested that the above prescription might have an inhibitory or even killing effect on tumor cells. T cell immunity of the treated mice was also improved as seen among patients.

摘要

158例晚期胃癌患者(男111例,女47例,年龄30 - 70岁)术后采用扶正祛邪的中药方剂联合化疗进行治疗。主要成分有党参、黄芪、白术、白毛藤、白花蛇舌草、丹参。根据患者就诊时的中医证候诊断,加减某些药物使方剂个体化。汤剂长期每日服用,三至四年甚至更长时间。单独服用或与化疗方案随机联合使用。3年和5年的平均生存率分别为41.07%和30.36%。7例患者存活超过11年。10年生存率为12.5%。中药与化疗联合使用优于单纯化疗方案(单用5 - 氟尿嘧啶或环己亚硝脲 + 5 - 氟尿嘧啶、丝裂霉素)。对幸存者的免疫学研究显示,体液免疫和细胞免疫均增强,尤其是外周NK细胞的功能。该汤剂已给予荷艾氏腹水瘤小鼠。腹水减少,癌细胞计数下降,同时动物的总体生存率显著提高。这表明上述方剂可能对肿瘤细胞有抑制甚至杀伤作用。如在患者中所见,经治疗的小鼠的T细胞免疫也得到改善。

相似文献

1
[Treatment of operated late gastric carcinoma with prescription of strengthening the patient's resistance and dispelling the invading evil in combination with chemotherapy: follow-up study of 158 patients and experimental study in animals].扶正祛邪方联合化疗治疗进展期胃癌:158例患者随访研究及动物实验研究
Zhong Xi Yi Jie He Za Zhi. 1990 Dec;10(12):712-6, 707.
2
[Clinical and experimental studies of shengxue tang combined with chemotherapy in the treatment of late-stage gastric cancer].升血汤联合化疗治疗晚期胃癌的临床与实验研究
Zhong Xi Yi Jie He Za Zhi. 1987 Dec;7(12):715-7, 707.
3
[Clinical effect of chemotherapy combined with Chinese herbs and western drugs on leukocytes of gastric cancer patients].化疗联合中西药对胃癌患者白细胞的临床疗效
Zhong Xi Yi Jie He Za Zhi. 1990 Dec;10(12):717-9, 707.
4
[Clinical study on early use of Chinese medicinal herbs and chemotherapy after operation of gastric cancer].[胃癌术后早期应用中药与化疗的临床研究]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1995 Aug;15(8):459-61.
5
Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.根治性胃切除术后辅助化疗的晚期胃癌患者15年随访期间预后因素模式的变化:韩国一家机构的15年随访研究
Ann Surg Oncol. 2007 Oct;14(10):2730-7. doi: 10.1245/s10434-007-9479-4. Epub 2007 Jul 14.
6
[Clinical and experimental study in treating gastric cancer with replenishing qi and invigorating spleen oral liquid combined with chemotherapy].[益气健脾口服液联合化疗治疗胃癌的临床与实验研究]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1994 Nov;14(11):661-3.
7
[The treatment of gastric carcinoma in III stage].[III期胃癌的治疗]
Zhonghua Wai Ke Za Zhi. 1995 Sep;33(9):548-50.
8
The effects of Chinese drugs for supporting healthy energy and removing blood stasis on postoperative metastasis of gastric carcinoma and ornithine decarboxylase.扶正祛瘀中药对胃癌术后转移及鸟氨酸脱羧酶的影响
J Tradit Chin Med. 1998 Mar;18(1):3-6.
9
Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.进展期胃癌非根治性胃切除术后的化疗
Hepatogastroenterology. 1999 Mar-Apr;46(26):1238-43.
10
[Clinical study on treatment of mid-late stage gastric carcinoma by composite xiansu capsule combined with chemotherapy].复方天仙素胶囊联合化疗治疗中晚期胃癌的临床研究
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1999 Aug;19(8):470-2.

引用本文的文献

1
Phase I clinical trial to evaluate the safety and pharmacokinetics of capsule formulation of the standardized extract of .评估[具体提取物名称]标准化提取物胶囊制剂安全性和药代动力学的I期临床试验。 (原文中提取物名称缺失)
J Tradit Complement Med. 2021 Feb 4;11(4):343-355. doi: 10.1016/j.jtcme.2021.02.002. eCollection 2021 Jul.
2
Application of genetic algorithm for discovery of core effective formulae in TCM clinical data.遗传算法在中医药临床数据核心有效方剂发现中的应用。
Comput Math Methods Med. 2013;2013:971272. doi: 10.1155/2013/971272. Epub 2013 Oct 30.
3
Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients.
增加 CIK 细胞过继免疫治疗的频率可能会降低胃癌患者的死亡风险。
World J Gastroenterol. 2010 Dec 28;16(48):6155-62. doi: 10.3748/wjg.v16.i48.6155.